Patents by Inventor Daniel PREISIG

Daniel PREISIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIPLE UNIT DOSAGE FORM COMPRISING A CORE WITH INDIVIDUAL CORE UNITS COVERED BY A MUCOADHESIVE MATERIAL AND AN ENTERIC CORE COATING
    Publication number: 20190336449
    Abstract: The present invention relates to a multiple unit dosage form comprising a core, wherein the core comprises a plurality of individual units, each unit comprising a pharmaceutically active ingredient and each unit being covered with a mucoadhesive material, and wherein the multiple unit dosage form further comprises an enteric core coating layer. The invention furthermore relates to the use of said multiple unit dosage form in the treatment of inflammatory disorders, especially for the gastrointestinal tract.
    Type: Application
    Filed: June 12, 2017
    Publication date: November 7, 2019
    Applicant: Tillotts Pharma AG
    Inventors: Felipe VARUM, Roberto BRAVO, Daniel PREISIG
  • Delayed release pharmaceutical formulation and methods of making and using same
    Patent number: 10391061
    Abstract: The present invention relates to a delayed release pharmaceutical formulation for delivering an active agent to the intestine, a method of preparing such formulation and the use of such formulation in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: August 27, 2019
    Assignee: Tillotts Pharma AG
    Inventors: Daniel Preisig, Maxim Puchkov, Joerg Huwyler, Felipe José Oliveira Varum, Roberto Carlos Bravo Gonzalez
  • DELAYED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF MAKING AND USING SAME
    Publication number: 20180125784
    Abstract: The present invention relates to a delayed release pharmaceutical formulation for delivering an active agent to the intestine, a method of preparing such formulation and the use of such formulation in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: January 9, 2018
    Publication date: May 10, 2018
    Applicant: Tillotts Pharma AG
    Inventors: Daniel Preisig, Maxim Puchkov, Joerg Huwyler, Felipe José Oliveira Varum, Roberto Carlos Bravo Gonzalez
  • Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
    Patent number: 9895314
    Abstract: The present invention relates to a delayed release pharmaceutical formulation for delivering an active agent to the intestine, a method of preparing such formulation and the use of such formulation in the treatment of gastrointestinal disorders, wherein the formulation includes at least one active agent associated with porous, functionalized calcium carbonate carrier particles that are surrounded by a material for colon targeting.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: February 20, 2018
    Assignee: Tillotts Pharma AG
    Inventors: Daniel Preisig, Maxim Puchkov, Joerg Huwyler, Felipe José Oliveira Varum, Roberto Carlos Bravo Gonzalez
  • DELAYED RELEASE PHARMACEUTICAL FORMULATION
    Publication number: 20160235673
    Abstract: The present invention relates to a delayed release pharmaceutical formulation for delivering an active agent to the intestine, a method of preparing such formulation and the use of such formulation in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 22, 2014
    Publication date: August 18, 2016
    Applicant: TILLOTTS PHARMA AG
    Inventors: Daniel PREISIG, Maxim PUCHKOV, Joerg HUWYLER, Felipe José OLIVEIRA VARUM, Roberto Carlos BRAVO GONZALEZ